Advances in Immunological Therapeutics – Vol 1 (2023 advances)

Over the past few decades, it has become increasingly clear that a weakened or overactive immune response underlies the development of many chronic conditions, ranging from autoimmune diseases to cancer. Advances in our understanding of our immune system has led to the development of therapies that modulate immune responses to treat various conditions with an immunological basis.  

In this HMX short course, you will learn from leading Harvard Medical School faculty about cutting-edge immunological therapeutics that have been recently approved by the FDA in 2023 for the treatment of a number of different chronic diseases. Learning how new therapies enhance or suppress our immune system is essential for anyone looking to develop or apply new immunomodulatory therapies to treat disease.